
ABOUT CRIO
CRIO, the leader in eSource technology, is an industry trailblazer transforming clinical research with the latest in cloud technology. CRIO's eSource enables remote monitoring and immediate data review with a powerfully integrated eSource/EDC solution that protects data integrity with built-in compliance across 21CFR11, ICH-GCP, GDPR, HIPAA, and other global regulations. CRIO’s eSource system allows users to enter data into a simple, interactive application, capturing data only once, at the moment of immediacy, without re-entering into EDC. Alerts, automatic calculations, and custom controls make data entry more efficient, timely and accurate - and because everything is available online, CRAs can monitor site operations remotely, and data managers can view data immediately.
Sponsor/CRO Solutions:
https://www.clinicalresearch.io/sponsors
Site Solutions:
https://www.clinicalresearch.io/clinical-trial-software
FEATURED SOLUTIONS
-
As the industry’s leading eSource provider, CRIO’s unique architecture enables a single point of data capture that embeds quality and transparency at the point of entry, which creates significant downstream efficiencies.
-
Explore how CRIO enables sites to obtain medical records, insurance, and more, with a click of a button.
-
CRIO eConsent is unique. It checks whether patients have executed the most recent informed consent at the outset of each visit.
-
As the leading eSource solution for sites worldwide, CRIO's unique architecture delivers a single point of data capture, eliminating the need for costly and delayed manual re-entry into EDC.
-
As the industry's leading provider of eSource to EDC integration, witness how CRIO grants complete control over clinical data by enabling remote monitoring, eliminating SDV, improving quality, and lowering costs.
-
Free yourself from the constraints of traditional EDC and take control of your clinical data. Save time, improve quality, and reduce costs with CRIO Reviewer (eSource/EDC).
CONTACT INFORMATION
CRIO
177 Huntington Ave. Suite 1703 PMB 32876
Boston, MA 02115
UNITED STATES
Phone: 617-302-9845
FEATURED ARTICLES
-
If a sponsor can properly query, centrally monitor, lock, and extract the data directly, understand why there is no longer a need for an EDC.
-
Often hiding in plain sight in the clinical research industry, discover how eSource presents a huge and ready-made opportunity for sponsors to conduct clinical trials more efficiently.
-
The FDA recommends that sponsors develop a plan to outline the operational measures that will be implemented. Delve into why this plan should include a “specific plan of action to enroll and retain diverse participants.”
-
eSource is the bridge between the protocol and the eCRF fields. To understand why, discover the need to understand what each does.
-
Read about the EMR’s (Electronic Medical Record) primary purpose: to give providers a flexible tool to document patient encounters and generate appropriate billing for insurance companies.
-
Discover how the solution to the "Re-Consent" problem in clinical trials is an infrastructure that enables real-time continuous monitoring and eliminates the need for secondary data entry, and hence, source data verification.
-
The clinical research industry made big changes to adapt to the operational disruptions of a global pandemic. In this article, learn about CRA experiences using a leading eSource technology platform.
-
Discover how the world's leading vaccine site network reduced protocol deviations by almost 40%.
-
Discover how the world's leading vaccine network adopted eSource during COVID-19 despite many obstacles that got in their way.
-
Despite the myriad of additional issues caused by COVID, explore how a study team’s efficiency dramatically increased with remote monitoring.
-
Discover an integrated eSource/EDC model, in which source data is collected electronically and then transmitted automatically, which in turn allows sponsors to review, query, code, lock, and extract the data.
-
Find out why the benefits of capturing data in real-time electronically are many fold for both sites and sponsors.